Assessment of delayed bleeding after endoscopic submucosal dissection of early-stage gastrointestinal tumors in patients receiving direct oral anticoagulants

doi:10.3748/wjg.v29.i19.2916

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 19

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4813)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

174

WORD

HTML

2607

Figures (1-1)

453

Tables (1-5)

389

Sum=3654

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

164

Download

425

Sum=589

Publishing Process of This Article

Item

Count

Browse

165

Download

405

Sum=570

May 21, 2023 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. May 21, 2023; 29(19): 2916-2931
Published online May 21, 2023. doi: 10.3748/wjg.v29.i19.2916

Open in New Tab Full Size Figure Download Figure

Figure 1 Post-endoscopic submucosal dissection bleeding-related factors. DOACs: Direct oral anticoagulants; NSAIDs: Non-steroidal anti-inflammatory drugs; CHADS: Congestive heart failure, Hypertension, Age > 75 years, Diabetes mellitus, and Stroke.

Citation: Sugimoto M, Murata M, Kawai T. Assessment of delayed bleeding after endoscopic submucosal dissection of early-stage gastrointestinal tumors in patients receiving direct oral anticoagulants. World J Gastroenterol 2023; 29(19): 2916-2931
URL: https://www.wjgnet.com/1007-9327/full/v29/i19/2916.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i19.2916